Open AccessTreatment of Clinically Diagnosed Laryngopharyngeal Reflux Disease
Author(s) -
Tarek Fouad Youssef,
Mohamed Ahmed
Publication year - 2010
Publication title -
archives of otolaryngology - head and neck surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-361X
pISSN - 0886-4470
DOI - 10.1001/archoto.2010.165
Subject(s) - esomeprazole , medicine , laryngopharyngeal reflux , clarithromycin , gastroenterology , helicobacter pylori , incidence (geometry) , gerd , laryngitis , proton pump inhibitor , surgery , reflux , disease , physics , optics
To determine the incidence of Helicobacter pylori (HP) stool antigen (HPSA) in patients with laryngopharyngeal reflux disease (LPRD), and to make a comparison of 2 treatment regimens that have been used based on the presence or absence of HPSA positivity in patients with LPRD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom